PIGF and hydrops fetalis: It has been reported that placental-like growth factor (PIGF) and soluble Fms-like tyrosine kinase-1 (sFlt-1) are associated with adverse outcomes in patients with heart failure (HF), and elevated levels of sFlt-1 are associated with adverse outcomes in stable patients with HF [8].